Lista de obras - Gabriele Stoffels - Dominio Público Uruguay

18F-FET PET differentiation of ring-enhancing brain lesions.

artículo científico publicado en 2006

5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma

artículo científico publicado en 2013

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours

artículo científico publicado en 2014

Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.

artículo científico publicado en 2012

Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.

artículo científico

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis

artículo científico publicado en 2018

Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.

artículo científico publicado en 2009

Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors

artículo científico publicado en 2014

Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study

artículo científico publicado en 2017

Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonanc

artículo científico publicado en 2018

Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study

scientific article published on 01 February 2020

Congruency of tumour volume delineated by FET PET and MRSI.

artículo científico publicado en 2015

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

artículo científico publicado en 2017

Detection of secondary thalamic degeneration after cortical infarction using cis-4-18F-fluoro-D-proline

artículo científico publicado en 2007

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

artículo científico publicado en 2014

Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma

artículo científico publicado en 2012

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

artículo científico publicado en 2007

Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia

artículo científico publicado en 2006

Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI

scientific article published on 15 June 2019

Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.

artículo científico publicado en 2015

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.

artículo científico publicado en 2016

Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.

artículo científico publicado en 2013

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

artículo científico publicado en 2018

Evaluation of factors influencing 18F-FET uptake in the brain

artículo científico publicado en 2017

Evaluation of new 18F-labeled amino acids for brain PET.

artículo científico publicado en 2005

Functional MRI vs. navigated TMS to optimize M1 seed volume delineation for DTI tractography. A prospective study in patients with brain tumours adjacent to the corticospinal tract.

artículo científico publicado en 2016

High resolution BrainPET combined with simultaneous MRI.

artículo científico publicado en 2011

Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.

artículo científico publicado en 2018

Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy

artículo científico publicado en 2013

Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET).

artículo científico publicado en 2017

Improved diagnostics of cerebral gliomas using FET PET

artículo científico publicado en 2007

Improved nTMS- and DTI-derived CST tractography through anatomical ROI seeding on anterior pontine level compared to internal capsule.

artículo científico publicado en 2015

Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-L-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake

artículo científico publicado en 2019

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.

artículo científico publicado en 2012

Invasive versus non-invasive mapping of the motor cortex

artículo científico publicado en 2020

Investigation of cis-4-[18F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment.

artículo científico publicado en 2018

Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET.

artículo científico

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.

artículo científico publicado en 2015

Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?

artículo científico publicado en 2013

Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach.

artículo científico publicado en 2015

Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

artículo científico publicado en 2012

NIMG-47. PHOTOPENIC DEFECTS ON O-(2-F-FLUOROETHYL)-L-TYROSINE PET - CLINICAL RELEVANCE IN GLIOMA PATIENTS

artículo científico publicado en 2017

O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres.

artículo científico publicado en 2017

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

artículo científico publicado en 2006

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

artículo científico publicado en 2005

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients

scientific article published on 01 October 2019

Predicting IDH genotype in gliomas using FET PET radiomics

artículo científico publicado en 2018

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET

artículo científico publicado en 2020

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

artículo científico publicado en 2011

Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.

artículo científico publicado en 2011

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

artículo científico publicado en 2007

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

artículo científico publicado en 2010

Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans

artículo científico publicado en 2016

Regional impairment of 18F-FDG uptake in the cervical spinal cord in patients with monosegmental chronic cervical myelopathy.

artículo científico publicado en 2010

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.

artículo científico publicado en 2016

Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas

artículo científico publicado en 2014

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.

artículo científico publicado en 2012

Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis

artículo científico publicado en 2012

Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma

artículo científico publicado en 2013

Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study

artículo científico

Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.

artículo científico publicado en 2017

The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord

artículo científico publicado en 2016

The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma

artículo científico publicado en 2015

The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents

artículo científico publicado en 2014

Treatment-Related Uptake of O-(2-18F-Fluoroethyl)-l-Tyrosine and l-[Methyl-3H]-Methionine After Tumor Resection in Rat Glioma Models

artículo científico publicado en 2019

Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results.

artículo científico publicado en 2014

Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.

artículo científico publicado en 2013

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

artículo científico publicado en 2018

cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humans.

artículo científico publicado en 2008

Lista de obras de Gabriele Stoffels

18F-FET PET differentiation of ring-enhancing brain lesions.

5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma

Adapting MR-BrainPET scans for comparison with conventional PET: experiences with dynamic FET-PET in brain tumours

Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI.

Clinical value of 2-deoxy-[18F]fluoro-D-glucose positron emission tomography in patients with cervical spondylotic myelopathy.

Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis

Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.

Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors

Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study

Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonanc

Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study

Congruency of tumour volume delineated by FET PET and MRSI.

Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease.

Detection of secondary thalamic degeneration after cortical infarction using cis-4-18F-fluoro-D-proline

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.

Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma

Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.

Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia

Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI

Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.

Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.

Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.

Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine.

Evaluation of factors influencing 18F-FET uptake in the brain

Evaluation of new 18F-labeled amino acids for brain PET.

Functional MRI vs. navigated TMS to optimize M1 seed volume delineation for DTI tractography. A prospective study in patients with brain tumours adjacent to the corticospinal tract.

High resolution BrainPET combined with simultaneous MRI.

Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI.

Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy

Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[(18)F]fluoroethyl)-L-tyrosine (FET).

Improved diagnostics of cerebral gliomas using FET PET

Improved nTMS- and DTI-derived CST tractography through anatomical ROI seeding on anterior pontine level compared to internal capsule.

Influence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-L-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.

Invasive versus non-invasive mapping of the motor cortex

Investigation of cis-4-[18F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment.

Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET.

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.

Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?

Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach.

Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

NIMG-47. PHOTOPENIC DEFECTS ON O-(2-F-FLUOROETHYL)-L-TYROSINE PET - CLINICAL RELEVANCE IN GLIOMA PATIENTS

O-(2-[18F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres.

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients

Predicting IDH genotype in gliomas using FET PET radiomics

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.

Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma.

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans

Regional impairment of 18F-FDG uptake in the cervical spinal cord in patients with monosegmental chronic cervical myelopathy.

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.

Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.

Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis

Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma

Spatial Relationship of Glioma Volume Derived from FET PET and Volumetric MRSI: a hybrid PET-MRI study

Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.

The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord

The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma

The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents

Treatment-Related Uptake of O-(2-18F-Fluoroethyl)-l-Tyrosine and l-[Methyl-3H]-Methionine After Tumor Resection in Rat Glioma Models

Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results.

Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.

Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience.

cis-4-[(18)F]-Fluoro-l-proline fails to detect peripheral tumors in humans.